Supplementazione con proteine del siero del latte, L-leucina e vitamina D per preservare la massa magra durante una dieta ipocalorica in donne con obesità sarcopenica

2022-06-15T13:16:56+02:00

Contributo di Caprio Supplementazione con proteine del siero del latte, L-leucina e vitamina D per preservare la massa magra durante una dieta ipocalorica in donne con obesità sarcopenica Whey Protein, L-Leucine and Vitamin D

Supplementazione con proteine del siero del latte, L-leucina e vitamina D per preservare la massa magra durante una dieta ipocalorica in donne con obesità sarcopenica2022-06-15T13:16:56+02:00

Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement.

2022-05-20T18:31:18+02:00

Contributo: Zoico Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Definizione e criteri diagnostici per Obesità sarcopenica: consensus statement dell’ European Society for Clinical Nutrition and Metabolism (ESPEN)

Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement.2022-05-20T18:31:18+02:00

The presence ofNAFLDinfluences the transition ofmetabolically healthy to metabolically unhealthy obesity and the ten-year cardiovascular disease risk: A population-based cohort study

2022-03-14T13:19:05+01:00

Contributo: Barrea The presence ofNAFLDinfluences the transition ofmetabolically healthy to metabolically unhealthy obesity and the ten-year cardiovascular disease risk: A population-based cohort study Background/objectives:We evaluated the role of the presence of non-alcoholic

The presence ofNAFLDinfluences the transition ofmetabolically healthy to metabolically unhealthy obesity and the ten-year cardiovascular disease risk: A population-based cohort study2022-03-14T13:19:05+01:00

The utility of the Edmonton Obesity Staging System for the prediction of COVID-19 outcomes: a multi-centre study

2022-02-16T16:48:56+01:00

Contributo: Barrea The utility of the Edmonton Obesity Staging System for the prediction of COVID-19 outcomes: a multi-centre study BACKGROUND: Patients with obesity have an increased risk for adverse COVID-19

The utility of the Edmonton Obesity Staging System for the prediction of COVID-19 outcomes: a multi-centre study2022-02-16T16:48:56+01:00

Age-appropriate BMI cut-points for cardiometabolic health risk: a cross-sectional analysis of the Canadian Longitudinal Study on Aging.

2022-02-16T16:44:03+01:00

Contributo: Zoico Age-appropriate BMI cut-points for cardiometabolic health risk: a cross-sectional analysis of the Canadian Longitudinal Study on Aging. Background Le modificazioni della composizione corporea associate all'invecchiamento si associano a

Age-appropriate BMI cut-points for cardiometabolic health risk: a cross-sectional analysis of the Canadian Longitudinal Study on Aging.2022-02-16T16:44:03+01:00

La massa grassa ha effetti sfavorevoli sull’osso, specialmente negli uomini: un’analisi trasversale del NHANES 2011-2018

2022-02-16T16:38:26+01:00

Contributo: Conte Titolo originale Fat Mass Has Negative Effects on Bone, Especially in Men: A Cross-Sectional Analysis of NHANES 2011-2018 Titolo in italiano La massa grassa ha effetti Abstract Contesto. L'effetto

La massa grassa ha effetti sfavorevoli sull’osso, specialmente negli uomini: un’analisi trasversale del NHANES 2011-20182022-02-16T16:38:26+01:00

Association of Weight Loss Achieved Through Metabolic Surgery With Risk and Severity of COVID-19 Infection

2022-01-26T17:13:56+01:00

Contributo: Maurizio De Luca Association of Weight Loss Achieved Through Metabolic Surgery With Risk and Severity of COVID-19 Infection Ali Aminian, Chao Tu, Alex Milinovich, Kathy E. Wolski, Michael W. Kattan, Steven E. Nissen JAMA Surg.  December 29, 2021.

Association of Weight Loss Achieved Through Metabolic Surgery With Risk and Severity of COVID-19 Infection2022-01-26T17:13:56+01:00

LOGIN SOCI

Torna in cima